Compare Johnson & Johnson (JNJ) vs Carparts.Com Inc (PRTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Carparts.Com Inc — how do they compare? Johnson & Johnson trades at $260.45 (market cap $626.09B), while Carparts.Com Inc trades at $6.35 (market cap $51.67M). The key difference: Johnson & Johnson is far larger — about 12117.1× Carparts.Com Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Carparts.Com Inc pays none. Which is the better fit depends on your goals.
| JNJ | PRTS | |
|---|---|---|
Market Cap | $626.09B | $51.67M |
Volume | 6,156,228 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $267.24 | $11.40 |
52-Week Low | $172.78 | $3.88 |
Enterprise Value | $654.37B | $66.64M |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.
Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.
PRTS trades at $6.35, up 0.47% today, with a bullish technical signal from moving averages. The company reported Q2 2026 earnings that beat expectations, with a net loss of -$0.43 per share versus -$0.85 expected. However, fundamentals show declining revenue from $676M in 2023 to $548M in 2025 and negative net income margins. A reverse stock split was executed on May 26, 2026, to maintain Nasdaq compliance.
The outlook is mixed: analyst consensus is 60% buy with no sell ratings, but persistent losses and negative cash flow from operations pose significant risks. Investment opportunity hinges on operational turnaround and proprietary data leverage, while high volatility and competitive pressures require caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Carparts.Com Inc
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →
